pyrroles has been researched along with Cancer of Jejunum in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yousef, AJA | 1 |
Fujiwara, T; Fujiwara, Y; Uno, F | 1 |
Fujita, T; Iwamoto, Y; Koike, H; Takeuchi, H; Tsujino, H | 1 |
Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Minato, H; Morioka, E; Nakano, Y; Nakata, S; Noguchi, M; Ohnishi, T; Ohno, Y; Omote, K; Takamura, H; Tomita, Y; Ueda, N | 1 |
4 other study(ies) available for pyrroles and Cancer of Jejunum
Article | Year |
---|---|
Jejunal Gastrointestinal Stromal Tumor.
Topics: Aged; Antineoplastic Agents; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Indoles; Jejunal Neoplasms; Jejunum; Male; Pyrroles; Sunitinib | 2017 |
[A long-term control of gastrointestinal stromal tumor with sunitinib].
Topics: Aged; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Indoles; Jejunal Neoplasms; Jejunostomy; Liver Neoplasms; Pyrroles; Sunitinib; Time Factors | 2013 |
Sunitinib treatment for multiple brain metastases from jejunal gastrointestinal stromal tumor: case report.
Topics: Aged; Angiogenesis Inhibitors; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Indoles; Jejunal Neoplasms; Magnetic Resonance Imaging; Male; Pyrroles; Radiosurgery; Sunitinib; Tomography, X-Ray Computed | 2014 |
[A case of drug resistant recurrent gastrointestinal stromal tumor treated surgically by resection, partial hepatectomy and diaphragmectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Diaphragm; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Jejunal Neoplasms; Liver Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Sunitinib | 2012 |